Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance

Diabetes

Volumn 50, Issue 6, 2001, Pages 1449-1454

  Båvenholm, Peter N ^a   Pigon, Jan ^a   Östenson, Claes Göran ^a   Efendic, Suad ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRITIUM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN INFUSION; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PRIORITY JOURNAL;

EID: 0034988204     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.6.1449     Document Type: Article

References (47)

1. Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus
2. Pathogenesis of NIDDM
3. Free fatty acids (FFA), a link between obesity and insulin resistance
4. Banting lecture 1988: Role of insulin resistance in human disease
5. Extrahepatic insulin sensitivity is enhanced in sedentary and endurance trained low insulin responders
6. Aspects of the pathogenesis of type 2 diabetes
7. Poor physical fitness, and impaired early insulin response but late hyperinsulinemia, as predictors of NIDDM in middle-aged Swedish men
8. Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes
9. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents
10. Insulin responses in equivocal and definite diabetes with special reference to subjects who had mild glucose intolerance but later developed definite diabetes
11. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus
12. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus: Role of hepatic and extrahepatic tissues
13. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance
14. The disposal of an oral glucose load in healthy subjects: A quantitative study
15. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: Comparison of unlabelled and labeled exogenous glucose infusates
16. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients
17. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting
18. Continuous in vivo determinations of blood glucose in human subjects
19. Immunoassay of insulin with insulin-antibody precipitate
20. Radioimmunological determination of human C-peptide in serum
21. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans: Assessment in absence of artifacts introduced by tritiated nonglucose contaminants
22. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps
23. Importance of periphereal insulin levels for insulin-induced suppression of glucose production in depancreatized dogs
24. Dexamethasone increases glucose cycling, but not glucose production, in healthy subjects
25. Experimental validation of measurements of glucose turnover in nonsteady state
26. Quantification of measurement error with Optimal Segments: Basis for adaptive time course smoothing
27. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus
28. Human kidney free fatty acid and glucose uptake: Evidence for a renal glucose-fatty acid cycle
29. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients
30. Effects of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans
31. Diminished B-cell secretory capacity in patients with non insulin dependent diabetes mellitus
32. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes using primed-continuous 3-3H-glucose infusion
33. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM
34. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
35. Insulin action in non-insulin-dependent diabetes mellitus: The relationship between hepatic and extrahepatic insulin resistance and obesity
36. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance
37. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus
38. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM
39. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus
40. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia
41. New concepts in extracellular signaling for insulin action: The single gateway hypothesis
42. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes
43. A comparison of the effects of a selective increase in periphereal or portal insulin on hepatic glucose production
44. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans
45. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction
46. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance